Fate Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| REDMILE GROUP, LLC | 02/14/2025 | 12.87 M | $21.24 M | -2.25% | 10.93% |
| BLACKROCK, INC. | 02/07/2025 | 10.94 M | $18.05 M | 4.47% | 9.29% |
| VANGUARD GROUP INC | 02/11/2025 | 10.33 M | $17.05 M | -0.68% | 8.77% |
| BELLEVUE GROUP AG | 02/14/2025 | 4.84 M | $7.99 M | 0.00% | 4.11% |
| CITADEL ADVISORS LLC | 02/14/2025 | 4.38 M | $7.23 M | 2.34% | 3.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/14/2025 | 3.56 M | $5.87 M | 0.00% | 3.02% |
| JOHNSON & JOHNSON | 02/13/2025 | 3.38 M | $5.58 M | 0.00% | 2.87% |
| BAKER BROS. ADVISORS LP | 02/14/2025 | 3.26 M | $5.38 M | 8.69% | 2.77% |
| ECOR1 CAPITAL, LLC | 02/14/2025 | 3.05 M | $5.03 M | 100.00% | 2.59% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 2.90 M | $4.78 M | 10.67% | 2.46% |
| MORGAN STANLEY | 02/14/2025 | 2.82 M | $4.66 M | -7.87% | 2.40% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 2.48 M | $4.09 M | -12.29% | 2.10% |
| VESTAL POINT CAPITAL, LP | 02/14/2025 | 2.47 M | $4.07 M | 46.29% | 2.09% |
| STATE STREET CORP | 02/14/2025 | 2.23 M | $3.68 M | -57.60% | 1.89% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 2.23 M | $3.68 M | -1.39% | 1.89% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.86 M | $3.06 M | 165.14% | 1.58% |
| ORBIMED ADVISORS LLC | 02/14/2025 | 1.68 M | $2.77 M | 0.00% | 1.43% |
| JPMORGAN CHASE & CO | 02/12/2025 | 1.67 M | $2.75 M | -9.13% | 1.42% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 02/14/2025 | 1.59 M | $2.62 M | -0.06% | 1.35% |
| D. E. SHAW & CO., INC. | 02/14/2025 | 1.54 M | $2.54 M | -54.51% | 1.30% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 1.47 M | $2.43 M | -8.01% | 1.25% |
| WOODLINE PARTNERS LP | 02/14/2025 | 1.42 M | $2.35 M | -53.59% | 1.21% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 02/14/2025 | 1.38 M | $2.28 M | -5.96% | 1.17% |
| UBS GROUP AG | 02/14/2025 | 1.10 M | $1.82 M | 172.93% | 0.94% |
| WALLEYE CAPITAL LLC | 02/13/2025 | 1.08 M | $1.79 M | 1,501.99% | 0.92% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 828,100 | $1.37 M | -10.69% | 0.70% |
| CERITY PARTNERS LLC | 02/13/2025 | 823,134 | $28,206 | 4,953.62% | 0.70% |
| NORTHERN TRUST CORP | 02/14/2025 | 805,518 | $1.33 M | -1.18% | 0.68% |
| CITIGROUP INC | 02/12/2025 | 781,889 | $1.29 M | 953.69% | 0.66% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 770,280 | $1.27 M | 0.85% | 0.65% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/14/2025 | 600,000 | $990,000 | -38.46% | 0.51% |
| FEDERATED HERMES, INC. | 02/13/2025 | 543,021 | $895,985 | -1.82% | 0.46% |
| MARSHALL WACE, LLP | 02/13/2025 | 512,641 | $845,857 | 100.00% | 0.44% |
| BARCLAYS PLC | 02/13/2025 | 416,731 | $687,000 | -1.78% | 0.35% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 413,192 | $681,767 | 52.69% | 0.35% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/14/2025 | 397,177 | $655,342 | 100.00% | 0.34% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 378,619 | $624,721 | 4.41% | 0.32% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 372,507 | $614,637 | -84.70% | 0.32% |
| FMR LLC | 02/13/2025 | 356,964 | $588,991 | 56.58% | 0.30% |
| BRUCE & CO., INC. | 02/11/2025 | 350,000 | $577,500 | 0.00% | 0.30% |
| E FUND MANAGEMENT CO., LTD. | 02/07/2025 | 339,994 | $560,990 | -3.89% | 0.29% |
| MONACO ASSET MANAGEMENT SAM | 02/10/2025 | 327,671 | $540,657 | 138.01% | 0.28% |
| PRUDENTIAL FINANCIAL INC | 02/11/2025 | 321,401 | $530,312 | -9.87% | 0.27% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 317,271 | $523,496 | 0.00% | 0.27% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 304,129 | $501,812 | -64.40% | 0.26% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 297,106 | $490,225 | -35.35% | 0.25% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 293,006 | $483,460 | -2.10% | 0.25% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 287,711 | $474,723 | 65.21% | 0.24% |
| XTX TOPCO LTD | 02/13/2025 | 249,800 | $412,170 | 100.00% | 0.21% |
| 02/12/2025 | 247,564 | $408,481 | 100.00% | 0.21% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Fate Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 242 institutional investors and hedge funds held shares of Fate Therapeutics, Inc.. The most heavily invested institutionals were:
Redmile Group, LLC: 12.87 M
BlackRock, Inc.: 10.94 M
VANGUARD GROUP INC: 10.33 M
Bellevue Group AG: 4.84 M
CITADEL ADVISORS LLC: 4.38 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 3.56 M
86.24% of Fate Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 124.77 M shares in the last 24 months. This purchase volume represents approximately $105.96 M in transactions.